Penicillin resistance is not extrapolable to amoxicillin resistance in Streptococcus pneumoniae isolated from middle ear fluid in children with acute otitis media

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 3, 2006, Pages 186-190

  Rosenblüt, Andrés ^a,d   Santolaya, María Elena ^b,c   Gonzalez, Patricia ^a   Borel, Cecilia ^b   Cofré, José ^b  

^a HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^b HOSPITAL LUIS CALVO MACKENNA   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d NONE   (Chile)

Author keywords

Acute otitis media; Antibiotic resistance; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; PENICILLIN G;

ACUTE OTITIS MEDIA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CHILE; DRUG CHOICE; EPILOMETER TEST; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; INFANT; MAJOR CLINICAL STUDY; MIDDLE EAR; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PUNCTURE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 33644925273     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611500305     Document Type: Article

References (30)

1. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis 1989;160:83-94.
2. Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J 2000;19:95-104.
3. [Erratum in Pediatr Infect Dis J 2000;19:275.]
4. Rosenblüt A, Santolaya ME, Gonzalez P, et al. Bacterial and viral etiology of acute otitis media in Chilean children. Pediatr Infect Dis J 2001;20:501-7.
5. Arguedas A, Dagan R, Soley C, et al. Microbiology of otitis media in Costa Rican children, 1999 through 2001. Pediatr Infect Dis J 2003;22:1063-8.
6. Hansman D, Bullen M. A resistant pneumococcus. Lancet 1967;2:264-5.
7. Baquero F, Martinez-Beltrán J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28(suppl C):31-8.
8. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992;146:920-3.
9. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996;174:986-93.
10. González P. Surveillance of antimicrobial resistance. Rev Chil Infectol 2002;19:S135-S139.
11. Kaplan SL, Mason EO Jr. Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann 2002;31:250-60.
12. Piglansky L, Leibovitz E, Raiz S, et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy off acute otitis media in children. Pediatr Infect Dis J 2003;22:405-13.
13. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451-65.
14. Jacobs MR. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J 2000;19 (suppl):S47-S56.
15. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance -a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1-9.
16. [Erratum in Pediatr Infect Dis J 1999;18:341.]
17. Durbin WJ. Pneumococcal infections. Pediatr Rev 2004;25:418-24.
18. Pérez-Trallero E, Fernández-Mazarrasa C, García-Rey C, et al; Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother 2001;45:3334-40.
19. File TM Jr. Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of β-lactam-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;34(suppl 1):S17-S26.
20. Viada J, Sáenz M, Bravo JP. Experiencia con el uso de una solución de prilocaína y lidocaína (EMLA®) como anestésico en procedimientos otológicos ambulatorios. Rev Chil Otorrinolaringol CirCabeza Cuello 1998;58:141-6.
21. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis 1997;176:1253-9.
22. Sorensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993;31:2097-100.
23. National Committee for Clinical Laboratory Standards 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. MIC Interpretative Standards for Streptococcus pneumoniae M100-S13 (M7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Bavestrello L, Cabello A, Casanova D. Impacto de las medidas regulatorias en la tendencia de consumo comunitario de antibióticos en Chile. Rev Med Chile 2002;130:1265-72.
25. Valenzuela MT, Prat S, Santolaya ME, et al. Implementación de una red nacional para la vigilancia de resistencia de agentes patógenos a antimicrobianos según síndromes clínicos. Rev Chil Infectol 2003;20:119-25.
26. Nagai K, Davies TA, Jacobs MR, Appelbaum PC. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible,- intermediate, and -resistant pneumococci. Antimicrob Agents Chemother 2002;46:1273-80.
27. Smith AM, Klugman KP. Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2001;45:2393-6.
28. Greenberg D, Speert DP, Mahenthiralingam E, Henry DA, Campbell ME, Scheifele DW; CPS/LCDC IMPACT Monitoring Network. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada. J Clin Microbiol 2002;40:68-74.
29. Hanage WP, Auranen K, Syrjanem R, et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun 2004;72:76-81.
30. Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines. J Infect Dis 2000;181:1322-9.